Literature DB >> 20149431

Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivo.

Bin Feng1, Kazuhito Tomizawa, Hiroyuki Michiue, Xiao-Jian Han, Shin-ichi Miyatake, Hideki Matsui.   

Abstract

The diverse characteristics of immunoliposomes provide advantages for utilization in drug delivery systems. In this study, we fused the antibody affinity motif of protein A (ZZ) with Gaussia luciferase (GLase). The fused protein conjugated with an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (GLase-ZZ-His-mAb) was effectively delivered into glioma cells expressing an activated EGFR mutant (EGFRvIII) and the bioluminescence was visualized in the cells. Immunoliposomes were further constructed with DSPE-PEG-MAL for covalent GLase-ZZ-His-mAb conjugation. A fluorescence dye (HPTS) encapsulated in immunoliposomes conjugated with GLase-ZZ-His-mAb was effectively delivered into EGFRvIII-expressing glioma cells. In a murine xenograft model of glioma, moreover, specific targeting of the immunoliposomes was visualized in the tumor. This new bifunctional immunoliposome system has the potential for drug delivery and imaging in vivo. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149431     DOI: 10.1016/j.biomaterials.2010.01.086

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Secreted luciferase for in vivo evaluation of systemic protein delivery in mice.

Authors:  Salim S El-Amouri; Phuong Cao; Carol Miao; Dao Pan
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

2.  Bioluminescence assay for detecting cell surface membrane protein expression.

Authors:  Mieko Kato; Tomoki Chiba; Min Li; Yoshiro Hanyu
Journal:  Assay Drug Dev Technol       Date:  2010-09-13       Impact factor: 1.738

3.  Inhibition of cell proliferation, migration and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain.

Authors:  Jiawen Yu; Meihua Guo; Ting Wang; Xiang Li; Dan Wang; Xinying Wang; Qian Zhang; Liang Wang; Yang Zhang; Chunhui Zhao; Bin Feng
Journal:  Cell Prolif       Date:  2016-02-03       Impact factor: 6.831

Review 4.  Rapid Detection Strategies for the Global Threat of Zika Virus: Current State, New Hypotheses, and Limitations.

Authors:  Shruti Shukla; Sung-Yong Hong; Soo Hyun Chung; Myunghee Kim
Journal:  Front Microbiol       Date:  2016-10-24       Impact factor: 5.640

5.  ICAM-1-Targeted Liposomes Loaded with Liver X Receptor Agonists Suppress PDGF-Induced Proliferation of Vascular Smooth Muscle Cells.

Authors:  Xu Huang; Meng-Qi Xu; Wei Zhang; Sai Ma; Weisheng Guo; Yabin Wang; Yan Zhang; Tiantian Gou; Yundai Chen; Xing-Jie Liang; Feng Cao
Journal:  Nanoscale Res Lett       Date:  2017-05-03       Impact factor: 4.703

6.  Development of recombinant rabies viruses vectors with Gaussia luciferase reporter based on Chinese vaccine strain CTN181.

Authors:  Jialiang Du; Qing Tang; Ying Huang; Willoughby E Rodney; Lihua Wang; Guodong Liang
Journal:  Virus Res       Date:  2011-05-27       Impact factor: 3.303

7.  Theranostic protein targeting ErbB2 for bioluminescence imaging and therapy for cancer.

Authors:  Xiao-Jian Han; Ling-Fei Sun; Yuki Nishiyama; Bin Feng; Hiroyuki Michiue; Masaharu Seno; Hideki Matsui; Kazuhito Tomizawa
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

8.  Development of a novel liposomal nanodelivery system for bioluminescence imaging and targeted drug delivery in ErbB2-overexpressing metastatic ovarian carcinoma.

Authors:  Xiao-Jian Han; Yong-Fang Wei; Yu-Ying Wan; Li-Ping Jiang; Jian-Feng Zhang; Hong-Bo Xin
Journal:  Int J Mol Med       Date:  2014-09-04       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.